Oxidized low-density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via toll-like receptors

Su Xin,Lihua Ao,Yi Shi,Thomas R. Johnson,David A. Fullerton,Xianzhong Meng
2011-01-01
Abstract:Vascular calcification is a common complication in atherosclerosis. Bone morphogenetic protein -2 (BMP-2) plays an important role in atherosclerotic vascular calcification. The aim of this study was to determine the effect of oxidized low-density lipoprotein (oxLDL) on BMP-2 protein expression in human coronary artery endothelial cells (CAECs), the roles of Toll-like receptor (TLR) 2 and TLR4 in oxLDLinduced BMP-2 expression and the signaling pathways involved. Human CAECs were stimulated with oxLDL. The roles of TLR2 and TLR4 in oxLDL-induced BMP-2 expression were determined by pretreatment with neutralizing antibody, siRNA and overexpression. Stimulation with oxLDL increased cellular BMP-2 protein levels in a dosedependent manner (40-160 μg/ml). Pretreatment with neutralizing antibodies against TLR2 and TLR4 or silencing these two receptors reduced oxLDL-induced BMP-2 expression. Over-expression of TLR2 and TLR4 enhanced the cellular BMP-2 response to oxLDL. Furthermore, oxLDL was colocalized with TLR2 and TLR4. BMP-2 expression was associated with activation of nuclear factor-κB (NF-κB), p38 mitogenactivated protein kinase (MAPK) and extracellular signal-related kinase (ERK) 1/2. Inhibition of NF-κB and ERK1/2 reduced BMP-2 expression while inhibition of p38 MAPK had no effect. In conclusion, oxLDL induces BMP-2 expression through TLR2 and TLR4 in human CAECs. The NF-κB and ERK1/2 pathways are involved in the signaling mechanism. These findings underscore an important role for TLR2 and TLR4 in mediating the BMP-2 response to oxLDL in human CAECs and indicate that these two immunoreceptors contribute to the mechanisms underlying atherosclerotic vascular calcification. Calcification in intima is often associated with atherosclerosis. Atherosclerotic calcification of coronary artery is a significant risk for the unsuccessful coronary intervention and ballooninduced coronary artery dissection (1), and calcification is found to be an indicator of plaque instability (2). While inhibition of atherosclerotic calcification might be a promising approach to stabilize atherosclerotic plaques, the molecular mechanism(s) underlying atherosclerotic cascular calcification remains incompletely understood. It is known that oxLDL accumulation in the vascular wall provokes the development of atherosclerosis and vascular calcification (3). BMP-2 is an osteogenic factor. It is expressed in calcified human atherosclerotic plaque. Cells from the atherogenic aortic wall express BMP-2 in vitro and formed calcified nodules with prolonged culture (4). BMP-2 mRNA level increased after oxLDL stimulation in human CAECs (5). However it remains unclear whether oxLDL up-regulates BMP-2 protein levels in CAECs. Further, the signaling mechanism that regulates cellular BMP-2 response to oxLDL is unknown. Accumulating evidence indicates that atherosclerosis is an inflammatory process involving a network of vascular cells, monocytes, T lymphocytes. Pro-inflammatory mediators, including cytokines, chemokines and growth factors, play critical roles in the inflammatory process associated with atherosclerosis. Native LDL and electronegative LDL increase the expression and release of interleukine (IL)-8, http://www.jbc.org/cgi/doi/10.1074/jbc.M110.214619 The latest version is at JBC Papers in Press. Published on February 16, 2011 as Manuscript M110.214619
What problem does this paper attempt to address?